Information de reference pour ce titreAccession Number: | 00004623-200205000-00022.
|
Author: | Huard, Johnny PhD; Li, Yong PhD, MD; Fu, Freddie H. MD
|
Institution: | Johnny Huard, PhD; Yong Li, PhD, MD; Growth and Development Laboratory, Children's Hospital of Pittsburgh, 4151 Rangos Research Center, 3705 Fifth Avenue, Pittsburgh, PA 15213. E-mail address for J. Huard: [email protected] Freddie H. Fu, MD; Department of Orthopaedic Surgery, University of Pittsburgh Medical Center, Liliane S. Kaufmann Building, 3471 Fifth Avenue, Suite 1010, Pittsburgh, PA 15213
|
Title: | |
Source: | Journal of Bone & Joint Surgery - American Volume. 84(5):822-832, May 2002.
|
References: | 1. Garrett WE Jr, Best TM. Anatomy, physiology, and mechanics of skeletal muscle. In: Simon SR, editor. Orthopaedic basic science. Rosemont, IL: American Academy of Orthopaedic Surgeons; 1994. p 89-125.
2. Bischoff R. The satellite cell and muscle regeneration. In: Engel AG, Franzini-Armstrong C, editors. Myology. Basic and clinical. 2nd ed. New York: McGraw-Hill; 1994. p 97-118.
3. Hurme T, Kalimo H. Activation of myogenic precursor cells after muscle injury. Med Sci Sports Exerc, 1992;24: 197-205..
4. Andersen JL, Schjerling P, Saltin B. Muscle, genes and athletic performance. Sci Am, 2000;283: 48-55..
5. Crisco JJ, Jokl P, Heinen GT, Connell MD, Panjabi MM. A muscle contusion injury model. Biomechanics, physiology, and histology. Am J Sports Med, 1994;22: 702-10..
6. Fukushima K, Badlani N, Usas A, Riano F, Fu F, Huard J. The use of an antifibrosis agent to improve muscle recovery after laceration. Am J Sports Med, 2001;29: 394-402..
7. Garrett WE Jr, Seaber AV, Boswick J, Urbaniak JR, Goldner JL. Recovery of skeletal muscle after laceration and repair. J Hand Surg [Am], 1984;9: 683-92..
8. Garrett WE Jr. Muscle strain injuries: clinical and basic aspects. Med Sci Sports Exerc, 1990;22: 436-43..
9. Hughes C 4th, Hasselman CT, Best TM, Martinez S, Garrett WE Jr. Incomplete, intrasubstance strain injuries of the rectus femoris muscle. Am J Sports Med, 1995;23: 500-6..
10. Jarvinen M, Sorvari T. Healing of a crush injury in rat striated muscle. 1. Description and testing of a new method of inducing a standard injury to the calf muscles. Acta Path Microbiol Scand [A], 1975;83: 259-65..
11. Kasemkijwattana C, Menetrey J, Day CS, Bosch P, Buranapanitkit B, Moreland MS, Fu FH, Watkins SC, Huard J. Biologic intervention in muscle healing and regeneration. Sports Med Arthroscopy Rev, 1998;6: 95-102..
12. Kasemkijwattana C, Menetrey J, Somogyl G, Moreland MS, Fu FH, Buranapanitkit B, Watkins SC, Huard J. Development of approaches to improve the healing following muscle contusion. Cell Transplant, 1998;7: 585-98..
13. Kasemkijwattana C, Menetrey J, Bosch P, Somogyi G, Moreland MS, Fu FH, Buranapanitkit B, Watkins SS, Huard J. Use of growth factors to improve muscle healing after strain injury. Clin Orthop, 2000;370: 272-85..
14. Lee CW, Fukushima K, Usas A, Xin L, Pelinkovich D, Martinek V, Somogyi G, Robbins PD, Fu FH, Huard J. Biological intervention based on cell and gene therapy to improve muscle healing after laceration. J Musculoskeletal Res, 2000;4: 265-77..
15. Menetrey J, Kasemkijwattana C, Fu FH, Moreland MS, Huard J. Suturing versus immobilization of a muscle laceration. A morphological and functional study in a mouse model. Am J Sports Med, 1999;27: 222-9..
16. Menetrey J, Kasemkijwattana C, Day CS, Bosch P, Vogt M, Fu FH, Moreland MS, Huard J. Growth factors improve muscle healing in vivo. J Bone Joint Surg Br, 2000;82: 131-7..
17. Miller KJ, Thaloor D, Matteson S, Pavlath GK. Hepatocyte growth factor affects satellite cell activation and differentiation in regenerating skeletal muscle. Am J Physiol Cell Physiol, 2000;278: 174-81..
18. Nikolaou PK, Macdonald BL, Glisson RR, Seaber AV, Garrett WE Jr. Biomechanical and histological evaluation of muscle after controlled strain injury. Am J Sports Med, 1987;15: 9-14..
19. Jarvinen TA, Kaariainen M, Jarvinen M, Kalimo H. Muscle strain injuries. Curr Opin Rheumatol, 2000;12: 155-61..
20. Best TM, Fiebig R, Corr DT, Brickson S, Ji L. Free radical activity, antioxidant enzyme, and glutathione changes with muscle stretch injury in rabbits. J Appl Physiol, 1999;87: 74-82..
21. Lille ST, Lefler SR, Mowlavi A, Suchy H, Boyle EM, Farr AL Jr, Su CY, Frank N, Mulligan DC. Inhibition of the initial wave of NF-kappaB activity in rat muscle reduces ischemia/reperfusion injury. Muscle Nerve, 2001;24: 534-41..
22. St Pierre BA, Tidball JG. Differential response of macrophage subpopulations to soleus muscle reloading after rat hindlimb suspension. J Appl Physiol, 1994;77: 290-7..
23. Hurme T, Kalimo H, Lehto H, Jarvinen M. Healing of skeletal muscle injury: an ultrastructural and immunohistochemical study. Med Sci Sports Exerc, 1991;23: 801-10..
24. Honda H, Kimura H, Rostami A. Demonstration and phenotypic characterization of resident macrophages in rat skeletal muscle. Immunology, 1990;70: 272-7..
25. Aronson D, Wojtaszewski JF, Thorell A, Nygren J, Zangen D, Richter EA, Ljungqvist O, Fielding RA, Goodyear LJ. Extracellular-regulated protein kinase cascades are activated in response to injury in human skeletal muscle. Am J Physiol, 1998;275(2 Pt 1): 555-61..
26. St Pierre Schneider B, Correia LA, Cannon JG. Sex differences in leukocyte invasion in injured murine skeletal muscle. Res Nurs Health, 1999;22: 243-50..
27. Pimorady-Esfahani A, Grounds MD, McMenamin PG. Macrophages and dendritic cells in normal and regenerating murine skeletal muscle. Muscle Nerve, 1997;20: 158-66..
28. Tidball JG. Inflammatory cell response to acute muscle injury. Med Sci Sports Exerc, 1995;27: 1022-32..
29. Cannon JG, St Pierre BA. Cytokines in exertion-induced skeletal muscle injury. Mol Cell Biochem, 1998;179: 159-67..
30. Altstaedt J, Kirchner H, Rink L. Cytokine production of neutrophils is limited to interleukin-8. Immunology, 1996;89: 563-8..
31. Best TM, Hunter KD. Muscle injury and repair. Phys Med Rehabil Clin N Am, 2000;11: 251-66..
32. Li Y, Cummins J, Huard J. Muscle injury and repair. Curr Opin Orthop, 2001;12: 409-15..
33. Russell B, Dix DJ, Haller DL, Jacobs-El J. Repair of injured skeletal muscle: a molecular approach. Med Sci Sports Exerc, 1992;24: 189-96..
34. Trippel SB, Coutts RD, Einhorn TA. Growth factors as therapeutic agents. J Bone Joint Surg Am, 1996;78: 1272-86..
35. Allen RE, Boxhorn LK. Regulation of skeletal muscle satellite cell proliferation and differentiation by transforming growth factor-beta, insulin-like growth factor-I, and fibroblast growth factor. J Cell Physiol, 1989;138: 311-5..
36. Anderson JE, Liu L, Kardami E. Distinctive patterns of basic fibroblast growth factor (bFGF) distribution in degenerative and regenerating areas of dystrophic (mdx) striated muscle. Dev Biol, 1991;147: 96-109..
37. Anderson JE. Murray L. Barr Award Lecture. Studies of the dynamics of skeletal muscle regeneration: the mouse came back. Biochem Cell Biol, 1998;76: 13-26..
38. Barnard W, Bower J, Brown MA, Murphy M, Austin L. Leukemia inhibitory factor (LIF) infusion stimulates skeletal muscle regeneration after injury: injured muscle expresses LIF mRNA. J Neurol Sci, 1994;123: 108-13..
39. Chambers RL, McDermott JC. Molecular basis of skeletal muscle regeneration. Can J Appl Physiol, 1996;21: 155-84..
40. Doumit ME, Cook DR, Merkel RA. Fibroblast growth factor, epidermal growth factor, insulin-like growth factors, and platelet-derived growth factor-BB stimulate proliferation of clonally derived porcine myogenic satellite cells. J Cell Physiol, 1993;157: 326-32..
41. Floss T, Arnold HH, Braun T. A role for FGF-6 in skeletal muscle regeneration. Genes Dev, 1997;11: 2040-51..
42. Florini JR, Roberts AB, Ewton DZ, Falen SL, Flanders KC, Sporn MB. Transforming growth factor-beta. A very potent inhibitor of myoblast differentiation, identical to the differentiation inhibitor secreted by Buffalo rat liver cells. J Biol Chem, 1986;261: 16509-13..
43. Gospodarowicz D, Weseman J, Moran JS, Lindstrom J. Effect of fibroblast growth factor on the division and fusion of bovine myoblasts. J Cell Biol, 1976;70: 395-405..
44. Grounds MD. Towards understanding skeletal muscle regeneration. Path Res Pract, 1991;187: 1-22..
45. Harrington MA, Daub R, Song A, Stasek J, Garcia JG. Interleukin 1 alpha mediated inhibition of myogenic terminal differentiation: increased sensitivity of Ha-ras transformed cultures. Cell Growth Diff, 1992;3: 241-8..
46. Jennische E, Hansson HA. Regenerating skeletal muscle cells express insulin-like growth factor I. Acta Physiol Scand, 1987;130: 327-32..
47. Jennische E. Sequential immunohistochemical expression of IGF-I and the transferin receptor in regenerating rat muscle in vivo. Acta Endocrinol (Copenh), 1989;121: 733-8..
48. Jin P, Rahm M, Claesson-Welsh L, Heldin CH, Sejersen T. Expression of PDGF A-chain and beta-receptor genes during rat myoblast differentiation. J Cell Biol, 1990;110: 1665-72..
49. Johnson SE, Allen RE. Activation of skeletal muscle satellite cells and the role of fibroblast growth factor receptors. Exper Cell Res, 1995;219: 449-53..
50. Keller HL, St Pierre Schneider B, Eppihimer LA, Cannon JG. Association of IGF-I and IGF-II with myofiber regeneration in vivo. Muscle Nerve, 1999;22: 347-54..
51. Kurek JB, Bower JJ, Romanella M, Koentgen F, Murphy M, Austin L. The role of leukemia inhibitory factor in skeletal muscle regeneration. Muscle Nerve, 1997;20: 815-22..
52. Lefaucheur JP, Sebille A. Muscle regeneration following injury can be modified in vivo by immune neutralization of basic fibroblast growth factor, transforming growth factor beta 1 or insulin-like growth factor I. J Neuroimmunol, 1995;57: 85-91..
53. Linkhart TA, Clegg CH, Hauschika SD. Myogenic differentiation in permanent clonal mouse myoblast cell lines: regulation by macromolecular growth factors in the culture medium. Dev Biol, 1981;86: 19-30..
54. Lyles JM, Amin W, Bock E, Weill CL. Regulation of NCAM by growth factors in serum-free myotube cultures. J Neurosci Res, 1993;34: 273-86..
55. McFarland DC, Pesall JE, Gilkerson KK. The influence of growth factors on turkey embryonic myoblasts and satellite cells in vitro. Gen Comp Endocrinol, 1993;89: 415-24..
56. Gal-Levi R, Leshem Y, Akoi S, Nakamura T, Halevy O. Hepatocyte growth factor plays a dual role in regulating skeletal muscle satellite cell proliferation and differentiation. Biochim Biophys Acta, 1998;1402: 39-51..
57. Olson EN, Sternberg E, Hu JS, Spizz G, Wilcox C. Regulation of myogenic differentiation by type beta transforming growth factor. J Cell Biol, 1986;103: 1799-805..
58. Yablonka-Reuvini Z, Balestrer TM, Bowen-Pope DF. Regulation of proliferation and differentiation of myoblasts derived from adult mouse skeletal muscle by specific isoforms of PDGF. J Cell Biol, 1990;111: 1623-9..
59. Damon SE, Haugk KL, Birnbaum RS, Quinn LS. Retrovirally mediated overexpression of insulin-like growth factor binding protein 4: evidence that insulin-like growth factor is required for skeletal muscle differentiation. J Cell Physiol, 1998;175: 109-20..
60. Engert JC, Berglund EB, Rosenthal N. Proliferation precedes differentiation in IGF-I stimulated myogenesis. J Cell Biol, 1996;135: 431-40..
61. Florini JR, Ewton DZ, Falen SZ, Van Wyk JJ. Biphasic concentration dependency of stimulation of myoblast differentiation by somatomedins. Am J Physiol, 1986;250: 771-8..
62. Quinn LS, Haugk KL. Overexpression of the type-1 insulin-like growth factor receptor increases ligand-dependent proliferation and differentiation in bovine skeletal myogenic cultures. J Cell Physiol, 1996;168: 34-41..
63. Florini JR, Ewton DZ, Coolican SA. Growth hormone and the insulin-like growth factor system in myogenesis. Endocr Rev, 1996;17: 481-517..
64. Zdanowicz MM, Moyse J, Wingertzahn MA, O'Connor M, Teichberg S, Slonim AE. Effect of insulin-like growth factor I in murine muscular dystrophy. Endocrinology, 1995;136: 4880-6..
65. Coleman ME, DeMayo F, Yin KC, Lee HM, Geske R, Montgomery C, Schwartz RJ. Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J Biol Chem, 1995;270: 12109-16..
66. Papadakis MA, Grady D, Black D, Tierney MJ, Gooding GA, Schambelan M, Grunfeld C. Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann Intern Med, 1996;124: 708-16..
67. Barton-Davis ER, Shoturma DI, Musaro A, Rosenthal N, Sweeney HL. Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc Natl Acad Sci U S A, 1998;95: 15603-7..
68. Lamberts SW, van den Beld AW, van der Lely AJ. The endocrinology of aging. Science, 1997;278: 419-24..
69. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev, 1995;16: 3-34..
70. Sheehan SM, Tatsumi R, Temm-Grove CJ, Allen RE. HGF is an autocrine growth factor for skeletal muscle satellite cells in vitro. Muscle Nerve, 2000;23: 239-45..
71. Sheehan SM, Allen RE. Skeletal muscle satellite cell proliferation in response to members of the fibroblast growth factor family and hepatocyte growth factor. J Cell Physiol, 1999;181: 499-506..
72. Tatsumi R, Anderson JE, Nevoret CJ, Halevy O, Allen RE. HGF/SF is present in normal adult skeletal muscle and is capable of activating satellite cells. Dev Biol, 1998;194: 114-28..
73. Springer ML, Chen AS, Kraft PE, Bednarski M, Blau HM. VEGF gene delivery to muscle: potential role for vasculogenesis in adults. Mol Cell, 1998;2: 549-58..
74. Gowdak LH, Poliakova L, Wang X, Kovesdi I, Fishbein KW, Zacheo A, Palumbo R, Straino S, Emanueli C, Marrocco-Trischitta M, Lakatta EG, Anversa P, Spencer RG, Talan M, Capogrossi MC. Adenovirus-mediated VEGF(121) gene transfer stimulates angiogenesis in normoperfused skeletal muscle and preserves tissue perfusion after induction of ischemia. Circulation, 2000;102: 565-71..
75. van Deutekom JC, Floyd SS, Booth DK, Oligino T, Krisky D, Marconi P, Glorioso JC, Huard J. Implications of maturation for viral gene delivery to skeletal muscle. Neuromuscular Disord, 1998;8: 135-48..
76. van Deutekom JC, Hoffman EP, Huard J. Muscle maturation: implications for gene therapy. Mol Med Today, 1998;4: 214-20..
77. Labhasetwar V, Bonadio J, Goldstein S, Chen W, Levy RJ. A DNA controlledrelease coating for gene transfer: transfection in skeletal and cardiac muscle. J Pharm Sci, 1998;87: 1347-50..
78. Appleton I, Tomlinson A, Colville-Nash PR, Willoughby DA. Temporal and spatial immunolocalization of cytokines in murine chronic granulomatous tissue. Implications for their role in tissue development and repair processes. Lab Invest, 1993;69: 405-14..
79. Barcellos-Hoff MH, Derynck R, Tsang ML, Weatherbee JA. Transforming growth factor-beta activation in irradiated murine mammary gland. J Clin Invest, 1994;93: 892-9..
80. Barnes JL, Abboud HE. Temporal expression of autocrine growth factors corresponds to morphological features of mesangial proliferation in Habu snake venom-induced glomerulonephritis. Am J Pathol, 1993;143: 1366-76..
81. Brandes ME, Allen JB, Ogawa Y, Wahl SM. Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals. J Clin Invest, 1991;87: 1108-13..
82. Coimbra T, Wiggins R, Noh JW, Merritt S, Phan SH. Transforming growth factor-beta production in anti-glomerular basement membrane disease in the rabbit. Am J Pathol, 1991;138: 223-34..
83. Czaja MJ, Weiner FR, Flanders KC, Giambrone MA, Wind R, Biempica L, Zern MA. In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis. J Cell Biol, 1989;108: 2477-82..
84. Jones CL, Buch S, Post M, McCulloch L, Liu E, Eddy AA. Pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosis. Kidney Int, 1991;40: 1020-31..
85. Kagami S, Border WA, Miller DE, Noble NA. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest, 1994;93: 2431-7..
86. Kaneto H, Morrissey J, Klahr S. Increased expression of TGF-beta 1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation. Kidney Int, 1993;44: 313-21..
87. Khalil N, Whitman C, Zuo L, Danielpour D, Greenberg A. Regulation of alveolar macrophage transforming growth factor-beta secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat. J Clin Invest, 1993;92: 1812-8..
88. Logan A, Berry M, Gonzalez AM, Frautschy SA, Sporn MB, Barid A. Effects of transforming growth factor beta 1 on scar production in the injured central nervous system of the rat. Eur J Neurosci, 1994;6: 355-63..
89. Okuda S, Languino LR, Ruoslahti E, Border WA. Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest, 1990;86: 453-62..
90. Sporn MB, Roberts AB. A major advance in the use of growth factors to enhance wound healing. J Clin Invest, 1993;92: 2565-6..
91. Terrell TG, Working PK, Chow CP, Green JD. Pathology of recombinant human transforming growth factor-beta 1 in rats and rabbits. Int Rev Exp Pathol, 1993;34: 43-67..
92. Westergren-Thorsson G, Hernnas J, Sarnstrand B, Oldberg A, Heinegard D, Malmstrom A. Altered expression of small proteoglycans, collagen, and transforming growth factor-beta 1 in developing bleomycin-induced pulmonary fibrosis in rats. J Clin Invest, 1993;92: 632-7..
93. Williams RS, Rossi AM, Chegini N, Schultz G. Effect of transforming growth factor beta on postoperative adhesion formation and intact peritoneum. J Surg Res, 1992;52: 65-70..
94. Wolf YG, Rasmussen LM, Ruoslahti E. Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model. J CIin Invest, 1994;93: 1172-8.
95. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA. Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci U S A, 1993;90: 1814-8..
96. Yamamoto T, Noble NA, Miller DE, Border WA. Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis. Kidney Int, 1994;45: 916-27..
97. Bernasconi P, Torchiana E, Confalonieri P, Brugnoni R, Barresi R, Mora M, Cornelio F, Morandi L, Mantegazza R. Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine. J Clin Invest, 1995;96: 1137-44..
98. Yamazaki M, Minota S, Sakurai H, Miyazono K, Yamada A, Kanazawa I, Kawai M. Expression of transforming growth factor-beta 1 and its relation to endomysial fibrosis in progressive muscular dystrophy. Am J Pathol, 1994;14: 221-6..
99. Amemiya K, Semino-Mora C, Granger RP, Dalakas MC. Downregulation of TGF-beta 1 mRNA and protein in the muscles of patients with inflammatory myopathies after treatment with high-dose intravenous immunoglobulin. Clin Immunol, 2000;94: 99-104..
100. Confalonieri P, Bernasconi P, Cornelio F, Mantegazza R. Transforming growth factor-beta 1 in polymyositis and dermatomyositis correlates with fibrosis but not with mononuclear cell infiltrate. J Neuropathol Exp Neurol, 1997;56: 479-84..
101. Tredget EE, Wang R, Shen Q, Scott PG, Ghahary A. Transforming growth factor-beta mRNA and protein in hypertrophic scar tissues and fibroblasts: antagonism by IFN-alpha and IFN-gamma in vitro and in vivo. J Interferon Cytokine Res, 2000;20: 143-51..
102. Zhang L, Mi J, Yu Y, Yao H, Chen H, Li M, Cao X. IFN-gamma gene therapy by intrasplenic hepatocyte transplantation: a novel strategy for reversing hepatic fibrosis in Schistosoma japonicum-infected mice. Parasite Immunol, 2001;23: 11-7..
103. Gurujeyalakshmi G, Giri SN. Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression. Exp Lung Res, 1995;21: 791-808..
104. Oldroyd SD, Thomas GL, Gabbiani G, El Nahas AM. Interferon-gamma inhibits experimental renal fibrosis. Kidney Int, 1999;56: 2116-27..
105. Mietz H, Krieglstein GK. Suramin to enhance glaucoma filtering procedures: a clinical comparison with mitomycin. Ophthalmic Surg Lasers, 2001;32: 358-69..
106. Kloen P, Jennings CL, Gebhardt MC, Springfield DS, Mankin HJ. Suramin inhibits growth and transforming growth factor-beta 1 (TGF-beta 1) binding in osteosarcoma cell lines. Eur J Cancer, 1994;30: 678-82..
107. Zein NN. Interferons in the management of viral hepatitis. Cytokines Cell Mol Ther, 1998;4: 229-41..
108. Friedlander L, van Thiel DH, Faruki H, Molloy PJ, Kania RJ, Hassanein T. New approach to HCV treatment. Recognition of disease process as systemic viral infection rather than as liver disease. Dig Dis Sci, 1996;41: 1678-81..
|
Language: | English.
|
Document Type: | Current Concepts Review.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 0021-9355
|
NLM Journal Code: | hjr, 0014030
|
Annotation(s) | |
|
|